K. Keyloun

发表

Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds

Gregory J. Crowther, Dustin J Maly, G. Drewes, 2016, PloS one.

Characterizing the Strength of Evidence in FDA Labels for Pharmacogenomic Biomarker-Guided Medication Use

Beth Devine, B. Devine, K. Keyloun, 2017, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.

Modeling operational quality metrics and costs of long-acting antibiotics for acute bacterial skin and skin structure infection treatment in the emergency department

E. Lofgren, K. Keyloun, S. Hebert, 2019, Journal of medical economics.

Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections.

K. Keyloun, P. González, M. Dunne, 2019, Journal of global antimicrobial resistance.

Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department

D. Nicolau, K. Keyloun, M. Nailor, 2018, BMC Health Services Research.

Impact of Outpatient vs Inpatient ABSSSI Treatment on Outcomes: A Retrospective Observational Analysis of Medical Charts Across US Emergency Departments

T. Jenkins, S. Doron, Jack Brown, 2018, Open forum infectious diseases.

Automating Electronic Clinical Data Capture for Quality Improvement and Research: The CERTAIN Validation Project of Real World Evidence

Peter Tarczy-Hornoch, Allison Devlin, David R Flum, 2018, EGEMS.

Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)

M. Thase, R. Hansen, E. Devine, 2017, CNS Drugs.

Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes.

Steven M. Johnson, Dustin J Maly, C. Verlinde, 2014, European journal of medicinal chemistry.

Bumped kinase inhibitor prohibits egression in Babesia bovis.

Dustin J Maly, W. V. Van Voorhis, Molly C. Reid, 2016, Veterinary parasitology.

Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial

T. Walsh, K. Keyloun, M. McCarthy, 2019, Infectious Diseases and Therapy.

Economic burden of hospital admissions for patients with acute bacterial skin and skin structure infections in the United States

M. Ganz, D. Weber, K. Keyloun, 2018, Hospital practice.

A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.

Dustin J Maly, A. White, W. V. Van Voorhis, 2013, The Journal of infectious diseases.

Structure determination of glycogen synthase kinase-3 from Leishmania major and comparative inhibitor structure-activity relationships with Trypanosoma brucei GSK-3.

C. Verlinde, W. Hol, E. Merritt, 2011, Molecular and biochemical parasitology.

Neospora caninum Calcium-Dependent Protein Kinase 1 Is an Effective Drug Target for Neosporosis Therapy

Dustin J Maly, W. Hol, E. Merritt, 2014, PloS one.

Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors

Dustin J Maly, F. Buckner, W. V. Voorhis, 2010, Nature Structural &Molecular Biology.

Pathway with single‐dose long‐acting intravenous antibiotic reduces emergency department hospitalizations of patients with skin infections

R. Rothman, D. Talan, G. Moran, 2021, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii

Dustin J Maly, W. V. Voorhis, C. Verlinde, 2010 .

Treatment Patterns During Major Depressive Episodes Among Patients with Major Depressive Disorder: A Retrospective Database Analysis

M. Bonafede, K. Keyloun, A. Cutler, 2022, Drugs - Real World Outcomes.

Characterizing Pharmacogenomic‐Guided Medication Use With a Clinical Data Repository

Peter Tarczy-Hornoch, Beth Devine, W. J. Wang, 2017, Clinical pharmacology and therapeutics.

Potent and selective inhibitors of CDPK1 from T. gondii and C. parvum based on a 5-aminopyrazole-4-carboxamide scaffold.

Dustin J Maly, K. Comess, C. Verlinde, 2014, ACS medicinal chemistry letters.

The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites

E. Merritt, Yifan Song, W. V. Van Voorhis, 2014, Parasitology.

Discovery of Potent and Selective Inhibitors of Calcium-Dependent Protein Kinase 1 (CDPK1) from C. parvum and T. gondii.

Dustin J Maly, C. Verlinde, E. Merritt, 2010, ACS medicinal chemistry letters.

Variability in Emergency Medicine Provider Decisions on Hospital Admission and Antibiotic Treatment in a Survey Study for Acute Bacterial Skin and Skin Structure Infections: Opportunities for Antimicrobial Stewardship Education

D. Nicolau, K. Keyloun, M. Nailor, 2018, Open forum infectious diseases.

A Retrospective Claims Analysis of Medication Adherence and Persistence Among Patients Taking Antidepressants for the Treatment of Major Depressive Disorder (MDD)

K. Keyloun, 2015 .

Annual costs among patients with major depressive disorder and the impact of key clinical events

M. Bonafede, K. Keyloun, A. Cutler, 2022, Journal of Managed Care & Specialty Pharmacy.

Clinical and economic burden of neovascular age-related macular degeneration by disease status: a US claims-based analysis

K. Keyloun, A. Almony, Chi-Chang Chen, 2021, Journal of managed care & specialty pharmacy.

A patient‐centred conceptual model of nocturnal scratch and its impact in atopic dermatitis: A mixed‐methods study supporting the development of novel digital measurements

K. Keyloun, F. Patalano, W. Begolka, 2023, Skin health and disease.

Fisher Digital Publications Fisher Digital Publications

S. Doron, K. Keyloun, P. Bookstaver, 2022 .

Characterizing the Strength of Evidence in FDA Labels for Pharmacogenomic Biomarker-Guided Medication Use

B. Devine, K. Keyloun, W. Canestaro, 2017, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.

Structure determination of glycogen synthase kinase-3 from Leishmania major and comparative inhibitor structure-activity relationships with Trypanosoma brucei GSK-3.

C. Verlinde, W. Hol, E. Merritt, 2011, Molecular and biochemical parasitology.